INC Research Holdings, Inc. (INCR) Shares Bought by Russell Investments Group Ltd.

Russell Investments Group Ltd. boosted its position in INC Research Holdings, Inc. (NASDAQ:INCR) by 9.5% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 649,834 shares of the company’s stock after buying an additional 56,405 shares during the period. Russell Investments Group Ltd. owned about 1.20% of INC Research Holdings worth $38,015,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently modified their holdings of INCR. BlackRock Inc. raised its position in shares of INC Research Holdings by 40,517.6% in the first quarter. BlackRock Inc. now owns 3,544,294 shares of the company’s stock worth $162,506,000 after buying an additional 3,535,568 shares during the period. MARSHALL WACE ASIA Ltd bought a new position in shares of INC Research Holdings during the first quarter valued at $37,634,000. Marshall Wace North America L.P. bought a new position in shares of INC Research Holdings during the first quarter valued at $37,634,000. Redmile Group LLC bought a new position in shares of INC Research Holdings during the first quarter valued at $29,059,000. Finally, Mackenzie Financial Corp raised its position in shares of INC Research Holdings by 93.1% in the first quarter. Mackenzie Financial Corp now owns 1,196,849 shares of the company’s stock valued at $54,876,000 after buying an additional 577,034 shares during the last quarter. Institutional investors and hedge funds own 99.84% of the company’s stock.

Shares of INC Research Holdings, Inc. (NASDAQ:INCR) traded up 0.63% during trading on Friday, reaching $56.00. 645,386 shares of the company traded hands. INC Research Holdings, Inc. has a 12 month low of $40.65 and a 12 month high of $61.10. The firm has a market capitalization of $3.03 billion, a PE ratio of 34.31 and a beta of 1.42. The firm has a 50-day moving average price of $56.38 and a 200-day moving average price of $52.08.

INC Research Holdings (NASDAQ:INCR) last posted its quarterly earnings data on Thursday, July 27th. The company reported $0.64 earnings per share for the quarter, hitting the consensus estimate of $0.64. The firm had revenue of $258.10 million for the quarter, compared to analysts’ expectations of $256.76 million. INC Research Holdings had a return on equity of 40.69% and a net margin of 5.69%. The company’s quarterly revenue was down .3% compared to the same quarter last year. During the same quarter last year, the business earned $0.61 EPS. Equities research analysts anticipate that INC Research Holdings, Inc. will post $2.61 EPS for the current year.

TRADEMARK VIOLATION NOTICE: This piece was first published by Community Financial News and is the sole property of of Community Financial News. If you are reading this piece on another domain, it was illegally copied and reposted in violation of US and international copyright and trademark laws. The legal version of this piece can be accessed at https://www.com-unik.info/2017/08/19/russell-investments-group-ltd-raises-stake-in-inc-research-holdings-inc-incr-updated-updated.html.

Several research analysts have weighed in on INCR shares. Robert W. Baird upgraded shares of INC Research Holdings from a “neutral” rating to an “outperform” rating and upped their target price for the stock from $46.00 to $66.00 in a research report on Thursday, May 11th. William Blair lowered shares of INC Research Holdings from an “outperform” rating to a “market perform” rating in a research report on Tuesday, June 20th. Goldman Sachs Group, Inc. (The) reaffirmed a “buy” rating and issued a $65.00 price target on shares of INC Research Holdings in a report on Monday, August 7th. KeyCorp raised shares of INC Research Holdings from a “sector weight” rating to an “overweight” rating and set a $68.00 price target on the stock in a report on Monday, June 5th. Finally, Jefferies Group LLC reaffirmed a “buy” rating and issued a $62.00 price target on shares of INC Research Holdings in a report on Friday, June 16th. One analyst has rated the stock with a sell rating, four have assigned a hold rating and five have given a buy rating to the company. The stock has a consensus rating of “Hold” and an average price target of $63.79.

In related news, CAO Christopher L. Gaenzle sold 6,873 shares of the firm’s stock in a transaction on Friday, June 30th. The stock was sold at an average price of $58.32, for a total value of $400,833.36. Following the transaction, the chief accounting officer now owns 47,450 shares in the company, valued at $2,767,284. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Alistair Macdonald sold 10,555 shares of the firm’s stock in a transaction on Monday, July 3rd. The stock was sold at an average price of $58.38, for a total value of $616,200.90. Following the completion of the transaction, the chief executive officer now owns 83,935 shares in the company, valued at approximately $4,900,125.30. The disclosure for this sale can be found here. 0.24% of the stock is owned by company insiders.

INC Research Holdings Company Profile

INC Research Holdings, Inc is a global contract research organization (CRO). The Company focuses on Phase I to Phase IV clinical development services for the biopharmaceutical and medical device industries. The Company operates through two segments: Clinical Development Services and Phase I Services.

Institutional Ownership by Quarter for INC Research Holdings (NASDAQ:INCR)

What are top analysts saying about INC Research Holdings Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for INC Research Holdings Inc. and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit